Latest filing published 17 Dec 2020 for 4D Molecular Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -57.5%Entry US$47.36 · Close at T+365 US$20.14
- -61.5%Entry US$442.20 · Close at T+365 US$170.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Tony Dung Ling Yao: trading record in brief
Tony Dung Ling Yao has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Precision Biosciences Inc and 4D Molecular Therapeutics, Inc. In total, 9 filings cover trades dated from 1 April 2019 to 15 December 2020.
The open-market record is one-sided, with 2 purchases worth €8.1M and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2020, the count stands at 1 purchase and no sales.
The newest entry dates from 17 December 2020: a transaction, in 4D Molecular Therapeutics, Inc. The most recent open-market purchase was published on 17 December 2020, 2,152 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Tony Dung Ling Yao
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,864 sharesCommon StockSEC:0001567619-20-021287:0
- 455,326 sharesCommon StockSEC:0001567619-20-021287:1
- 180,554 sharesCommon StockSEC:0001567619-20-021287:2
- 425,000 shares@ US$23.00100.0% of flowCommon StockSEC:0001567619-20-021287:3Canonical exit: 15 Mar 2021 (T+90)
- 6,487 shares@ US$15.4216.6% of flowCommon StockSEC:0001209191-19-023673:0Canonical exit: 2 Jul 2019 (T+90)
- 4,450 sharesCommon StockSEC:0001209191-19-022659:3
- 4,450 sharesCommon StockSEC:0001209191-19-022659:0
- 114,570 sharesCommon StockSEC:0001209191-19-022659:2
- 36,946 shares@ US$13.6083.4% of flowCommon StockSEC:0001209191-19-022659:1
9 of 9 declarations
